These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1675549)

  • 1. Cardiovascular pharmacology of adrenergic and dopaminergic receptors: therapeutic significance in congestive heart failure.
    Lokhandwala MF; Hegde SS
    Am J Med; 1991 May; 90(5B):2S-9S. PubMed ID: 1675549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New dopamine agonists in cardiovascular therapy].
    Girbes AR; Van Veldhuisen DJ; Smit AJ
    Presse Med; 1992 Aug 29-Sep 5; 21(27):1287-91. PubMed ID: 1359528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of dopamine receptors in the treatment of congestive heart failure.
    Goldberg LI
    J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S19-27. PubMed ID: 2478806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ibopamine--pharmacologic principles].
    Borchard U
    Z Kardiol; 1991; 80 Suppl 8():63-6. PubMed ID: 1686693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profile of ibopamine. A summary of experiments on anaesthesized dogs.
    Marchetti GV
    Cardiology; 1990; 77 Suppl 5():22-9. PubMed ID: 1980631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dopexamine: a new dopaminergic agonist].
    Perrin G; Papazian L; Martin C
    Ann Fr Anesth Reanim; 1993; 12(3):308-20. PubMed ID: 7902685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent separation of dopaminergic and adrenergic effects of epinine in healthy volunteers.
    Daul A; Elter-Schulz M; Poller U; Jockenhövel F; Pönicke K; Boomsma F; Man in't Veld AJ; Schäfes RF; Brodde OE
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):429-37. PubMed ID: 8532072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardiovascular actions of dopexamine hydrochloride, an agonist at dopamine receptors and beta 2-adrenoceptors in the dog.
    Smith GW; Hall JC; Farmer JB; Simpson WT
    J Pharm Pharmacol; 1987 Aug; 39(8):636-41. PubMed ID: 2888855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective and nonselective dopamine receptor agonists: an innovative approach to cardiovascular disease treatment.
    Frishman WH; Hotchkiss H
    Am Heart J; 1996 Oct; 132(4):861-70. PubMed ID: 8831378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine and the kidney in heart failure.
    Casagrande C
    Herz; 1991 Apr; 16(2):102-15. PubMed ID: 2066052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-mediated inotropic drugs.
    van Zwieten PA
    Eur Heart J; 1988 Jun; 9 Suppl H():85-90. PubMed ID: 2901958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of dopamine receptors and the utility of dopamine agonists in heart failure.
    Rajfer SI; Davis FR
    Circulation; 1990 Aug; 82(2 Suppl):I97-102. PubMed ID: 1973645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibopamine in chronic congestive heart failure: hemodynamic and neurohumoral effects.
    López-Sendón J
    Am J Med; 1991 May; 90(5B):43S-49S. PubMed ID: 1675551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor systems involved in norepinephrine release in heart failure: focus on dopaminergic systems.
    Francis GS
    Clin Cardiol; 1995 Mar; 18(3 Suppl I):I13-6. PubMed ID: 7743693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.
    Brown RA; Dixon J; Farmer JB; Hall JC; Humphries RG; Ince F; O'Connor SE; Simpson WT; Smith GW
    Br J Pharmacol; 1985 Jul; 85(3):599-608. PubMed ID: 2862944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of dopaminergic drugs for the chronic treatment of congestive heart failure.
    Casagrande C; Merlo L; La Regina A
    J Auton Pharmacol; 1990; 10 Suppl 1():s85-93. PubMed ID: 1983011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dopaminergic agents on cardiac and renal function in normal man and in patients with congestive heart failure.
    van Veldhuisen DJ; Girbes AR; de Graeff PA; Lie KI
    Int J Cardiol; 1992 Dec; 37(3):293-300. PubMed ID: 1361484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dopamine receptor in adult and maturing kidney.
    Felder RA; Felder CC; Eisner GM; Jose PA
    Am J Physiol; 1989 Sep; 257(3 Pt 2):F315-27. PubMed ID: 2571302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine and new dopamine analogs: receptors and clinical applications.
    Goldberg LI
    J Clin Anesth; 1988; 1(1):66-74. PubMed ID: 2908484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.